Immunotherapy Weekly articles from April 2004

Immunotherapy Weekly archives from April 2004

Arthritis suppressor genes TIA-1 and TTP vanquish arthritogenic cytokines.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Arthritis suppressor genes TIA-1 and TTP vanquish arthritogenic cytokines. According to published research from the United States, "TIA-1 and TTP are AU-rich element-binding proteins that prevent...

Immune cells fight cancer's return, predict outcome after stem-cell transplant.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- By measuring levels of cells crucial to marshaling the forces of the immune system, University of Florida (UF) researchers have been able to predict with greater accuracy the likelihood cancer patients...

Homocysteine has potent and diverse effects on immune activity.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Homocysteine (Hcy) exerts potent and wide-ranging influence on immune activity. Elevated Hcy levels "have been identified as independent risk identifiers for cardiovascular disease, cerebrovascular...

CpG oligonucleotides elicit antitumor responses in melanoma models.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- CpG oligonucleotides elicit antitumor responses in melanoma models. "For patients with advanced malignant melanoma, the 5 year survival rate with current treatment modalities is low. There is an...

Expression by DNA-transfected DCs occurs through terminal differentiation.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Highly efficient expression of transgenic proteins by naked DNA-transfected dendritic cells (DCs) occurs through terminal differentiation. "Dendritic cells play a key role in the induction and...

Rac controls cellular redox state.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Rac controls the cellular redox state. According to recent research published in the Journal of Cell Science, "In neutrophils and other phagocytic cells, the small GTPase Rac is an essential...

Test kit launched to check for residential indoor allergens.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- American Home Laboratories, Inc., (AHL) announced the launch of AllergenREPORT, a home test kit that screens for elevated levels of residential indoor allergens, including dust mite, cockroach, cat, and...

Alternaria stimulates a case of life-threatening asthma.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Alternaria stimulates a case of life-threatening asthma. "Acute, severe asthma attacks can be precipitated by a variety of stimuli including exposure to aeroallergens, viral respiratory infections,...

Microglial activation facilitates A-beta plaque removal.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Microglial activation facilitates A-beta plaque removal following intracranial anti-A beta antibody administration. According to a study from the United States, "The mechanisms by which anti-A-beta...

ABthrax found to be safe and well tolerated.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Human Genome Sciences, Inc., (HGSI) announced that the results of a phase I clinical trial demonstrate that ABthrax (human monoclonal antibody to Bacillus anthracis protective antigen) is safe and well...

Hartford ranked 10th worst city in the U.S. for asthma patients.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A new report says Hartford, Connecticut, is the 10th worst metropolitan area in the United States for asthmatics. The nonprofit group Asthma and Allergy Foundation of America report is based on...

Kos announces strategic acquisition of Azmacort franchise.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Kos Pharmaceuticals, Inc., (KOSP) has entered into a product acquisition agreement with Aventis Pharmaceuticals Holdings, Inc., and a supply agreement with Aventis Pharmaceuticals, Inc., to acquire...

Study: Inhaled steroid therapy does not reduce fetal growth.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Inhaled steroid therapy by pregnant women with asthma does not lead to a restriction in fetal growth, according to a new study. In the largest sample to date examining the potential effects that...

FluMist maker announces plan to achieve $2 billion in revenues by 2009.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., (MEDI) announced that it expects to achieve $2 billion in total revenues by 2009, driven by investments in its pipeline and the continued growth of its currently marketed products. ...

Everolimus may prevent rejection and vasculopathy after heart transplantation.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Everolimus may prevent rejection and vasculopathy after heart transplantation. According to published information from New Zealand, "the main cause of illness and death after the first year of heart...

AT1 receptor blocker increases efficacy of ACE inhibitors in murine DHF model.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- AT1 receptor blockade enhances the effects of ACE inhibitor treatment in a murine model of late-stage diastolic heart failure (DHF). DHF "has become a social burden; however, evidences leading to...

Novel flow cytometry assay aids study of myocardial inflammation.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A novel flow cytometry-based assay facilitates the study of myocardial inflammation. "Inflammation has been increasingly recognized as an important pathological component of heart failure,"...

Cell cycle progression is critical for CD40-mediated B cell survival.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Cell cycle progression is critical for CD40-mediated B cell survival. "The CD40 molecule transmits a signal that abrogates apoptosis induced by ligation of the antigen receptor (BCR) in both primary...

Hepatitis B core antigen makes T cells and monocytes secrete interleukin-10.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Hepatitis B core antigen makes T cells and monocytes secrete interleukin-10. "In chronic hepatitis B virus (HBV) infection, immune responses to hepatitis B core antigen (HBcAg) are weak. Interleukin...

FDA approves Sensipar for the treatment of secondary hyperparathyroidism.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Amgen, Inc., (AMGN) announced that the U.S. Food and Drug Administration (FDA) approved Sensipar (cinacalcet HCl) following a priority review. Sensipar, an innovative, first-in-class oral...

Enrollment status announced for Oxytrex phase III study.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Pain Therapeutics, Inc., (PTIE) has enrolled more than 350 patients in its first phase III study with Oxytrex, an oral painkiller being developed by the company to treat severe chronic pain. "This...

Genaera extends alliance IL-9 alliance.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Genaera Corp. (GENR) and the Ludwig Institute for Cancer Research (LICR) announced a 2-year extension of a collaborative agreement on the joint discovery and development of novel genes and proteins as...

Phase II colorectal vaccine trial results updated.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM, BRA) provided an update of data from the phase II Theratope vaccine colorectal study of 20 patients. A Kaplan-Meier Survival and Time to Disease Progression Curve of the 20...

Bronchoalveolar lavage T-cell subset ratios delineate respiratory diseases.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Bronchoalveolar lavage T-cell subset ratios delineate respiratory diseases. According to recent research published in the Journal of Immunological Methods, "alterations in bronchoalveolar lavage...

Trial results advance development of vaccine for travelers' diarrhea.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A clinical trial undertaken by the U.K. biotechnology company Microscience at the St. George's Vaccine Institute at St. George's Hospital Medical School in London, England has demonstrated the safety...

Epidermal growth factor receptor inhibitors should stall cancer growth.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Epidermal growth factor receptor inhibitors should stall cancer growth. According to recent research published in the International Journal of Radiation Oncology, Biology, Physics, "in cancer cells,...

Vaccine development helps drive company's 25% revenue increase in 2003.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- GenVec, Inc., (GNVC), announced financial results for the fourth quarter and year ended December 31, 2003. For the year ended December 31, 2003, GenVec reported a net loss of $21.3 million or $0.65...

Senate passes Food Allergen Labeling and Consumer Protection Act.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- New food label legislation, recently passed by the Senate, is an important step forward in providing clear, consistent, and reliable ingredient label information - an essential first line of defense for...

Tumor necrosis factor-alpha reduces D-fructose intestinal transport.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Tumor necrosis factor-alpha reduced D-fructose intestinal transport in rabbits. According to a study from Spain, "Tumor necrosis factor-alpha (TNF-alpha) is an important immunoregulatory cytokine...

B cells develop and transcribe immunoglobulin despite Oct-1 deficiency.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- B cells develop and transcribe immunoglobulin despite Oct-1 deficiency. "The POU domain transcription factors Oct-1 and Oct-2 interact with the octAm element, a motif conserved within immunoglobulin...

Vestigial theta-defensin pseudogenes identified in humans.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A group of vestigial theta-defensin pseudogenes have been identified in the human genome. According to recent research from the United States, "[r]etrocyclins (ancestral human theta-defensins) are...

FDA accepts NDA for oxypurinol.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Cardiome Pharma Corp. (COM) announced that the U.S. Food and Drug Administration (FDA) has accepted for review Cardiome's New Drug Application (NDA) for oxypurinol for the treatment of...

Twice-daily CsA prophylaxis more effective than continuous infusion.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Twice-daily administration of CsA prevents GVHD more effectively than a continuous infusion of the immunosuppressant. In a recent study, scientists in Japan "retrospectively compared the...

NIH grant to fund drug development for multidrug-resistant HIV.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Chimerix, Inc., a biotechnology company developing orally available, targeted medicines for the treatment of smallpox, multidrug-resistant HIV and hepatitis virus infections, has been awarded a Phase I...

High-mannose-type oligosaccharides bind to human antibody 2G12.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- High-mannose-type oligosaccharides bind to human antibody 2G12, which has implications for HIV-1 vaccine design. According to a study from the United States, "Human antibody 2G12 broadly...

HIV p24 antigen test can detect subtype G strains.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- The p24 antigen HIV test can detect subtype G strains. "The expense of PCR testing limits diagnosis of HIV infection in infancy in low resource settings," scientists in South Africa explained. ...

Vitamin A supplements may increase risk of vertical HIV transmission.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Vitamin A supplements may increase the risk of vertical HIV transmission. According to recent research from the United States, "[m]icronutrient status has been associated with shedding of human...

IFN-alpha with ribavirin can suppress virus-specific immunity.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Treatment with interferon (IFN)-alpha and ribavirin may impair immune responses to non-HCV viruses. Anti-HCV treatment "combining IFN-alpha and ribavirin (IFN+R) has still poorly defined effects on...

Immunosuppressive therapy diminishes pancytopenia in a child with monosomy 7.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- According to a study from Japan, "monosomy 7 syndrome in infants is considered a pre-leukemic condition of poor prognosis. However, it seems controversial recently, because some cases of monosomy 7...

Hepatitis A peptide covalently linked to liposomes.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A hepatitis A peptide has been covalently linked to liposomes. "In this work we have studied the conjugation of the immunogenic peptide sequence (110-121) belonging to the VP3 capsid protein of...

Bacteriophage-mediated nucleic acid immunization offers benefits.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Bacteriophage-mediated nucleic acid immunization offers benefits over naked DNA vaccines. "Whole bacteriophage lambda particles, containing reporter genes under the control of the cytomegalovirus...

Self-reported hepatitis B vaccination status unreliable among drug users.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Self-reported hepatitis B virus infection and vaccination status among young drug users is unreliable. "Self-reported hepatitis B virus (HBV) infection status and immunization status were compared...

Nabi to supply Novaplus Nabi-HB.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Nabi Biopharmaceuticals (NABI) has signed an agreement with Novation, LLC, to supply Nabi-HB, [Hepatitis B Immune Globulin (Human)] through Novation's Novaplus Private Label Program. Novaplus, the...

Hepatitis C DNA vaccine induces strong DTH response in mice.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A hepatitis C virus core protein-expressing DNA vaccine induced a strong class I-binding peptide DTH response in mice. "The hepatitis C virus (HCV) core protein-encoding sequence (HCcAg) is the...

Common virus may contribute to uncommon bone disease in children.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A common virus may play a major role in causing a painful disease of immune cells that attacks children's bones, according to a new study. The research may eventually lead to an easier diagnosis and...

CpG methylation of plasmid vectors circumvents immune response activation.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- CpG methylation of plasmid vectors circumvents immune response activation. According to a study from the United States, "gene therapy has the potential to cure inherited diseases if the delivered...

Data presented on molecular mechanism of action for HE2000.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Hollis-Eden Pharmaceuticals, Inc., (HEPH) announced the presentation of additional data relating to the molecular mechanism of action by which its immune regulating hormone IMMUNITIN (HE2000) may...

Effects of morphine on HIV gp160-induced monocyte apoptosis clarified.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- The effects of morphine on HIV gp160-induced monocyte apoptosis have been clarified. In a recent study, neuroimmunologists in New York examined "the effect of HIV-l gp160 protein and morphine on...

Myeloperoxidase expression identifies acute myeloblastic leukemia variants.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Myeloperoxidase expression identifies acute myeloblastic leukemia variants. According to researchers in Russia, "we studied morphocytochemical and immunophenotypic features of blast cells in 14...

Positive results reported from Xibrom U.S. phase III trials.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- ISTA Pharmaceuticals, Inc., (ISTA) announced positive, statistically significant results from its initial analysis of the company's U.S. phase III clinical trials of Xibrom (0.1% bromfenac sodium...

Significant differences divide alloimmune and conventional immune response.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Significant differences divide alloimmune and conventional immune response. "Signaling through toll-like receptors (TLRs) is believed to be the critical first step in the activation of antigen...

Similarities between HIV infection and aging may aid fight against both.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Immunological similarities between HIV infection and aging may point to strategies for ameliorating both conditions. "Aging and HIV disease show certain immunological similarities," scientists in...

The 4H84 mAb can bind to non-HLA-G molecules.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- The 4H84 mAb can bind to molecules other than HLA-G. In a recent study, scientists in Slovenia found that the "4H84 monoclonal antibody (mAb) used for detection of beta[subscript]2m free HLA-G...

Vectors harboring liver-restricted promoter yield long term gene expression.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Vectors harboring liver-restricted promoter yield long-term gene expression. "The successful application of gene therapy for the treatment of genetic diseases such as Fabry is reliant on the...

Transcription factor and PPAR interactions block response element binding.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Transcription factor and PPAR interactions block response element binding. "Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors, originally implicated in...

Influenza A viruses obtained from Vero cells by reverse genetics.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- High-yielding influenza A viruses obtained from African green monkey kidney (Vero) cells by reverse genetics. "Influenza A viruses are the cause of annual epidemics of human disease with occasional...

African Americans in Atlanta unaware of high kidney disease risk.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Although kidney failure and its leading causes disproportionately affect African Americans, they are largely unaware of their high risk and of preventive measures, according to the first U.S. National...

Geron Corp. inks agreement for therapeutic cancer-vaccine technology.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Geron Corp. (GERN) and Merix Bioscience, Inc., have executed an agreement under which Geron has acquired the exclusive right to use Merix's platform technology in therapeutic cancer vaccines using the...

Hemozoin has potent inflammatory effects in mice.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Hemozoin has potent inflammatory effects in a murine malaria model. "During malaria infection, high levels of proinflammatory molecules (e.g., cytokines, chemokines) correlate with disease...

New approach needed for proper medication use by transplant patients.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Nearly all organ transplant recipients need lifelong immunosuppressant drug treatment to prevent rejection of the foreign organ. Yet despite potentially dire consequences, many patients do not follow...

Busulphan-cyclophosphamide conditioning safe, effective for auto-SCT.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A myeloablative busulphan-cyclophosphamide conditioning regimen is safe and effective before stem-cell autotransplantation. According to recent research from the United States, both "single and...

MHC- and TCR-binding residues of myelin glycoprotein peptide characterized.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Scientists have characterized the MHC- and TCR-binding residues of the myelin oligodendrocyte glycoprotein 38-51 peptide. "Myelin oligodendrocyte glycoprotein (MOG) is a major experimental...

CD40 plays key role in induction of anti-M. avium immunity.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- CD40 plays a key role in the efficient induction of anti-Mycobacterium avium immunity. In a recent study from Portugal, "C57Bl/6 mice and mice deficient in the CD40 molecule were infected with three...

Myelitis presents as a first symptom of systemic lupus erythematosus.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Myelitis presents as a first symptom of systemic lupus erythematosus. "Transverse myelitis is a rare and serious complication of systemic lupus erythematosus (SLE). A longitudinal involvement of the...

Pregnant women can safely take Claritin, study reports.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Schering-Plough's widely used allergy drug Claritin (loratadine) does not cause genital birth defects in boys when taken by their mothers during early pregnancy, according to a study from the U.S....

Some electric utility workers show reduced levels of immune system cells.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Some electric utility workers show reduced levels of immune system cells. "The effects of a 60-Hz magnetic field (MF) exposure on white blood cell ornithine decarboxylase (ODC) activity, natural...

Interleukin-15 enhances the antitumor efficacy of CD8+ T Cells.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Interleukin-15 enhances the antitumor efficacy of CD8+ T Cells. "Interleukin (IL)-15 and IL-2 possess similar properties, including the ability to induce T cell proliferation. However, whereas IL-2...

Joint function discussed at meeting.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A new theory of joint function presented in a symposium at the 71st annual meeting of the American Academy of Orthopaedic Surgeons suggests that the development of osteoarthritis in the knee following...

Orthovisc launched for osteoarthritis knee pain.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Ortho Biotech Products, L.P., introduced Orthovisc (High Molecular Weight Hyaluronan), a new treatment option for patients suffering from pain due to osteoarthritis (OA) of the knee, at the annual...

Obesity increases risk of osteoarthritis.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Obesity increases the risk of osteoarthritis. According to recent research from France, "Obesity and osteoarthritis are frequently associated, particularly in older patients. Obesity increases the...

Postnatal steroids may harm long-term cognitive development.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Postnatal steroids may harm long-term cognitive development. According to recent research from the United States, "in this study, we investigated the effect of dexamethasone on the long-term...

Bosko Djordjevic elected to board of directors.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Lipid Sciences, Inc., (LIPD) announced that Bosko Djordjevic was elected to the board of directors on March 2, 2004. Lipid Sciences is a development-stage biotechnology company engaged in the...

Company announces organizational changes.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- As part of its Horizon 2010 long-term strategy, Genentech, Inc., (DNA) announced organizational changes in the development, commercial, and manufacturing functions. The new structure is designed to...

Diagnostics company announces board and management appointments.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Hemagen Diagnostics, Inc., (OB) a biotechnology company that develops, manufactures, and markets proprietary medical diagnostic test kits, announced that Edward T. Lutz was elected to the board of...

Immunotherapy company appoints Claude Miller vice president of quality.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Genitope Corp. (GTOP) announced the appointment of Claude Miller as vice president of quality. Miller will be responsible for the quality assurance and quality control functions supporting Genitope...

Isaac Kier joins board.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Hudson Health Sciences, Inc., (HHS), a biopharmaceutical company headquartered in San Francisco, California, has elected Isaac Kier to its board of directors. Kier is a general partner of Coqui...

Pharmaceutical company announces new member of corporate advisory board.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Provectus Pharmaceuticals, Inc., (PVCT) announced that Gregory H. Bailey, MD, has been appointed to serve on the company's newly formed corporate advisory board. Expanding Provectus' base of...

Pharmaceutical company promotes Gail Sloan to VP.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- La Jolla Pharmaceutical Co. (LJPC) announced the promotion of Gail Sloan to vice president of finance, controller, and secretary. "Gail has played an important role in the growth and progress of...

ACT antibody response low after failed pertussis vaccination.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Adenylate cyclase toxin (ACT) antibody response was low in patients who experienced failed Bordetella pertussis immunization. According to recent research from the United States, "Presence of...

Infant growth not adversely affected by inhaled steroids during pregnancy.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- A national multi-center study coordinated by Kaiser Permanente has shown that pregnant women can safely use inhaled steroids to manage their persistent asthma without adversely affecting the growth of...

Combination of medication, light therapy increases presence of HPV in skin.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Patients with psoriasis who have been treated with a combination of drug (psoralen) and ultraviolet light therapy have an increased prevalence of human papillomavirus (HPV) in their skin, according to...

Hispanics face significant disparities in pharmaceutical treatment.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- Hispanics are less likely to receive or use medications for asthma, cardiovascular disease, HIV/AIDS, mental illness, and pain, according to a new study. These disparities in pharmaceutical...

ERK-1/2 activation is a prerequisite for respiratory synctial virus infection.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- ERK-1/2 activation is a prerequisite for respiratory synctial virus infection. According to recent research published in the journal FEBS Letters, "respiratory syncytial virus (RSV) infection...

MR imaging of toxoplasmosis encephalitis in BMT recipients characterized.
April 7, 2004... 2004 APR 7 - (NewsRx.com & NewsRx.net) -- The magnetic resonance (MR) imaging of toxoplasmosis encephalitis in immunocompromised patients has been characterized. Radiologists in the United States described their experience with "a patient...